Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 May 22];4(5):s63. Available from: https://skin.dermsquared.com/skin/article/view/1012